Flawed Clinical Trials Did Not Prove Safety
Wyeth Lederle and Kaiser Permanente compared their pneumococcal vaccine against another vaccine (a meningococcal vaccine), which seriously compromised the scientific validity of the trial. Even so, children in groups who received their pneumococcal vaccine suffered more irritability, seizures, high fevers and other reactions. There were 12 deaths in the Prevnar pneumococcal) group, including 5 Sudden Infant Death Syndrome (SIDS) deaths.(1) There have been over 3500 Prevnar-related adverse events reported to the federal government (VAERS) since it was licensed in 2000 — including 476 serious events and 79 deaths.(2)
Pneumococcal Vaccine Causes Ear Infections
Another study by Kilpi, et al in1980 showed that the vaccine group’s children encountered 33% more ear infections.
No Long Term Safety Studies
There were no long term studies to evaluate whether Prevnar vaccine given alone or in combination with other vaccines is associated with chronic illness or disability, such as the development of diabetes, asthma, seizure disorders, learning disabilities, ADHD, or autism.
Vaccine Components Not Thoroughly Evaluated
Each injection of Prevnar contains 0.125 mg. of aluminum, a metal that is highly neurotoxic. The vaccine manufacturer states that “Prevnar has not been evaluated for any carcinogenic or mutagenic potential, or impairment of fertility.” (1,4)
- Wyeth-Lederle Product Manufacturer Insert (Pneumococcal 7-Valent Conjugate Vaccine (PREVNAR). Issued February 2000.
- Vaccine Adverse Event Reporting System (VAERS) Data
- Centers for Disease Control. Dec. 10,2001 press release: ACIP Votes to Temporarily Revise Recommendations for Pneumococcal Conjugate Vaccine, www.cdc.gov/nip/news/shortages/default.htm
- Aluminum Toxicity in Infants and Children (RE9607). Pediatrics. Vol. 97, No. 3 (March 1996).
Studies by Forrester et al 1987, Austrian 1981, Ortqvisdt et al 1988, Fine et al 1994 and Simberkoff et al 1986 all show that the pneumococcal vaccines exhibit very poor ability to produce sufficient antibodies (which even then, does not ensure protection) and prevent pneumococcal pneumonia disease.
Many Strains, Many Mutations
Pneumococcal vaccines contain only a few of the more than 90 strains of the pneumococcal mincroorganism that causes disease in humans and cannot prevent meningitis or blood infections caused by other strains. These bacterium adapt and mutate as most germs do.
Pneumococcal Vaccines by Brand
|Pneumovax II Pneumococcal Vaccine, Polyvalent|
|Manufacturer||Sanofi Pasteur MSD|
|Microorganism||Most common types for S. pneumoniae bacteria|
|Recommendations||Single 0.5 mL i.m. or s.c. injection for adults and children 2 years of age or older.|
|Ingredients||Phenol, Sodium chloride|
|Pneumovax® 23 Pneumococcal 23-valent polysaccharide vaccine (PS), inactivated|
|Microorganism||S. pneumoniae, serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, 33F|
|Recommendations||One i.m. or s.c. injection and a booster is recommended.|
|Ingredients||Phenol, Pneumococcal Polysaccharide(s), Isotonic saline|
|Product Descriptions||Package insert|
|Pnu-Imune® 23 (PS) 23-valent polysaccharide vaccine|
|Microorganism||S. pneumoniae bacteria|
|Recommendations||Single i.m. or s.c. injection for those 2 years of age and older.|
|Ingredients||Thimerosal, 2-(ethylmercurithio) benzoic acid, Pneumococcal Polysaccharide(s)|
|Prevnar® Pneumococcal Conjugate Vaccine 7-valent, inactivated|
|Microorganism||S. pneumonia bacteria, serotypes 4, 9V, 14, 18C, 19F, and 23F|
|Recommendations||4 i.m. injections at 2, 4, 6, and 12 to 15 months of age.|
|Ingredients||Latex, Aluminum phosphate, Soy protein|